Cargando...
Cost-Effectiveness and Public Health Impact of Influenza Vaccine Strategies for US Seniors
OBJECTIVES: Four influenza vaccines are available in the US for persons aged ≥65 years: trivalent inactivated influenza vaccine (IIV3), quadrivalent inactivated influenza vaccine (IIV4), a more expensive high-dose IIV3, and a newly approved adjuvanted IIV3, but their cost-effectiveness when all 4 va...
Guardado en:
| Publicado en: | J Am Geriatr Soc |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5302117/ https://ncbi.nlm.nih.gov/pubmed/27709600 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jgs.14323 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|